<DOC>
	<DOCNO>NCT01361529</DOCNO>
	<brief_summary>The purpose study determine tolerance maximum tolerate dose ( MTD ) FLP Injection multiple dose tumor patient .</brief_summary>
	<brief_title>Safety Study FLP Injection Treat Tumor Patients</brief_title>
	<detailed_description>To determine tolerance MTD FLP Injection multiple dose tumor patient . To test clinical pharmacokinetics ( PK ) PK parameter</detailed_description>
	<criteria>age 18 70 year old , male female ; histologically cytologically proven advanced malignant solid tumor ; cancer patient conventional treatment failure lack effective treatment , patient refuse effective treatment exist practice ; patient receive last treatment ( chemotherapy , radiotherapy , biological therapy , target therapy , study drug ) least 4 week ; expect survival time &gt; 3 month ; ECOG score 01 viral activity patient allergic drug excipients ; hypersensitivity paclitaxel injection patient ; HIV antibody positive , suffer acquire congenital immune deficiency disease , history organ transplantation ; neutrophil count &lt; 1.5 × 109 / L , platelets &lt; 100 × 109 / L , hemoglobin &lt; 90g / L ; normal serum creatinine high 1.5 time upper limit reference range muscle liver clearance &lt; 60ml/min ; case liver ALT AST &gt; 2.5 time upper limit normal , liver metastasis normal ALT AST 5 time upper limit reference range ; fever body temperature 38 ℃ clinically significant impact clinical trial active infection ; medication fail control hypertension ( systolic pressure 160 mmHg diastolic pressure 100mmHg ) ; significant cardiovascular abnormality ( myocardial infarction , superior vena cava syndrome ) , clinically significant arrhythmia ( long QT syndrome , Corrected QTc measure ≧ 480 m ) ; calcium , potassium , magnesium ion low limit normal ; &gt; Ilevel peripheral neuropathy Prior toxicity anticancer therapy restore surgery full recovery ; bone metastases primary lesion palliative radiotherapy ; clinical problem control ( serious mental , neurological , cardiovascular , respiratory disease ) ; tumor metastasis , variety mental disorder center ; history asthma ; pregnancy breastfeed woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2011</verification_date>
	<keyword>dose escalation</keyword>
</DOC>